|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.6640 - 0.6900|
|52 Week Range||0.5000 - 2.7400|
|Beta (5Y Monthly)||-1.66|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 09, 2020 - Feb 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Seattle, Washington--(Newsfile Corp. - January 13, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing General Cannabis and the next level for investors: Cannabis 3.0.https://www.generalcann.com/To view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/5503/51374_ab246126e4984a61_001full.jpgRemember when investments in cannabis and Bitcoin were seen as interchangeable pursuits of the next sky-high return based on a story that sounded plausible, ...
General Cannabis Corp (CANN), a company with deep domain expertise in providing services to the cannabis industry, today announced that it has signed a non-binding term sheet to acquire Hälsa Holdings Inc, a company led by industry experts and created to acquire assets in mature markets. When the acquisition is complete, General Cannabis will acquire contracts to acquire three dispensaries in California, and add a deeply experienced team to its existing executive group. The acquisition is expected to close in Q1 2020, subject to entry into definitive documentation.
As it prepares to roll out its “Cannabis 3.0” growth strategy over the coming weeks, General Cannabis Corp. (CANN) and its newly appointed CEO Steve Gutterman today announced several strategic steps that will further focus the company’s operations and strengthen its balance sheet. Among the steps announced today, General Cannabis Corp. said it plans to expand the operations around its highly successful and profitable cultivation consulting business, Next Big Crop, while shedding several non-core business units.
General Cannabis Corp (CANN), a leading provider of products and services to the regulated cannabis industry, today announced that Steve Gutterman—one of the cannabis industry’s most recognized leaders—has joined the company as Chief Executive Officer and a member of its Board of Directors, effective immediately. Michael Feinsod, who has served as CEO since January, steps down from that role while continuing as Executive Chairman of the company. Gutterman brings more than two decades of success building and leading high growth businesses in highly regulated industries, with an extraordinary record of having increased annual revenue and market capitalization of the companies he has led by over $500 million and $2 billion, respectively.
General Cannabis Corp. announced today it has entered into a contract for the sale of its Greenhouse Office building in Denver, Colorado for $1,697,500. General Cannabis acquired the property in 2014 for $1,050,000. The closing is subject to customary conditions.
DENVER, Nov. 08, 2019 -- General Cannabis Corp (OTCQX: CANN) (“General Cannabis” or the “Company”), the comprehensive national resource to the regulated cannabis industry,.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
It is anticipated that General Cannabis will pay consideration consisting of fifty percent cash and fifty percent in shares of the Company’s common stock for virtually all of the tangible and intangible assets of the Business. This potential transaction follows the Company’s recent announcements of its entry into non-binding term sheets to acquire other licensed cannabis entities in Colorado. “We are pleased to announce our plans to acquire a fourth licensed Colorado cannabis operator,” said Michael Feinsod, Executive Chairman and Chief Executive Officer of General Cannabis. “This planned acquisition would expand our retail business to Boulder.
DENVER, CO / ACCESSWIRE / October 17, 2019 / CEOCFO Magazine, an independent investment, cannabis, and medical news publication highlights an executive change at General Cannabis (CANN) in an interview (https://www.ceocfointerviews.com/interviews/GeneralCannabis19.htm) with Michael Feinsod, Executive Chairman of General Cannabis since 2014, and CEO since January of 2019, who says "we collectivity agreed that this is the time to focus on new and active acquisitions in Colorado and that I would be a natural leader to drive the effort". States Mr. Feinsod, "my background in investment management is exactly the thing that positioned me to be able to spot a quality acquisition when I see it. During my four years as Executive Chairman, not only did I lead the acquisitions at General Cannabis, but I have been very involved in the company overall and it's been a positive experience".
This potential transaction follows the Company’s recent announcement of its entry into non-binding term sheets to acquire other licensed cannabis entities in Colorado. The Company is taking these actions based on the signing of Colorado House Bill 1090 (“HB-1090”), a recently approved law allowing public companies to own Colorado-licensed cannabis companies. Once the regulations surrounding the implementation of the law are finalized, the Company plans to enter into a binding transaction for the Business.
General Cannabis Corporation (CANN), the comprehensive resource to the regulated cannabis industry, announced today that veteran communications and public affairs executive Seth Oster has been elected to its Board of Directors. Oster has over 25 years of experience leading corporate communications, marketing and public affairs efforts at high levels of the federal government and in the private sector.
DENVER, Aug. 12, 2019 -- General Cannabis Corp (OTCQX: CANN) (“General Cannabis” or the “Company”), the comprehensive national resource to the regulated cannabis industry,.
General Cannabis Corp (CANN) (the “Company”), the comprehensive national resource to the regulated cannabis industry, today announced that it has entered into a non-binding term sheet to acquire substantially all of the assets of a licensed recreational cannabis cultivator and retailer in Denver, Colorado (the “Business”). The seller of the Business operates two indoor cultivation facilities and a retail cannabis dispensary in central Denver to manage the Business. The Business has been rated one of the best dispensaries in Denver by High Times magazine, and is the holder of a library of world-class cannabis genetics.
This potential transaction follows the Company’s recent announcement of its entry into a non-binding term sheet to acquire substantially all of the assets of The Organic Seed, LLC, doing business as Cannaseur. The Company is taking these actions based on the signing of Colorado House Bill 1090 (“HB-1090”), a recently approved law allowing public companies to own Colorado-licensed cannabis companies. Once the regulations surrounding the implementation of the law are finalized, the Company plans to enter into a binding transaction for the Business.
If you're interested in Heritage Cannabis Holdings Corp. (CNSX:CANN), then you might want to consider its beta (a...
General Cannabis Corp (CANN), the comprehensive resource for the highest quality service providers available to the regulated cannabis industry, announced the promotion of Richard Cardinal to Vice President. In support of a growth plan to acquire licensed marijuana cultivators and retailers across the country, Cardinal will have expanded responsibilities going forward. "After four years of successfully growing our Next Big Crop division, promoting Rich to this new position is a natural. Rich and his team have successfully helped cultivate thousands of pounds of cannabis over the past few years," said General Cannabis' Chairman and CEO Michael Feinsod. As General Cannabis continues to execute on our plan to own and operate leading cannabis cultivation, infused-products manufacturing and dispensing businesses across the country, I look forward to overseeing these future operations, and to leveraging the economies of scale and operational data that will be realized through our model,” noted Richard Cardinal.
General Cannabis Corp (CANN) (the “Company”), the comprehensive national resource to the regulated cannabis industry, today announced that it has entered into a non-binding term sheet to acquire substantially all of the assets of The Organic Seed, LLC, doing business as Cannaseur (“Cannaseur”). Cannaseur is a vertically integrated cannabis license holder located in Pueblo West, Colorado. In addition to the Cannaseur dispensary and cultivation facility, the term sheet also includes their infused products line, Dabtek. General Cannabis is taking this action based on the signing of Colorado House Bill 1090 (“HB-1090”), a recently approved law allowing public companies to own Colorado licensed cannabis companies. Once the regulations surrounding the implementation of the law are finalized, the Company plans to enter into a binding transaction.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
GENERAL CANNABIS CORP (OTCQX: CANN) (“General Cannabis” or the “Company”), the comprehensive national resource to the regulated cannabis industry, today announced it has entered into definitive agreements with investors for the purchase and sale of (i) 3,000,000 shares of common stock, par value $0.001 per share, and (ii) warrants to purchase up to 3,000,000 shares of common stock at a combined offering price of $1.00 per share, pursuant to a registered direct offering. The Company intends to use the net proceeds for general corporate purposes, which may include, among other things, product development, acquisitions, capital expenditures, repayment of existing indebtedness and other business opportunities. This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-222907) previously filed with the U.S. Securities and Exchange Commission (the “SEC”), on February 7, 2018, and declared effective on February 12, 2018.
Cannabis stocks and exchange-traded funds fell Friday. Among cannabis stocks tracked by TheStreet, two rose while nine fell. General Cannabis shares rose 6 cents, or 3.77%, to $1.65. Tilray shares fell $1.
Cannabis stocks ended mixed Wednesday. Trading was muted after results from Aurora Cannabis and Tilray showed big jumps in revenue, but mixed results on the bottom line. Among 10 notable cannabis stocks tracked by TheStreet, six rose while four fell.
DENVER, May 09, 2019 -- General Cannabis Corp (OTCQX: CANN) (the “Company”), the comprehensive national resource to the regulated cannabis industry, today announced financial.
You may find it surprising, but the Post Office, the Atlanta Hawks and these seven marijuana stocks all have something in common. At first glance, you may think they have nothing to do with each other. After all, the Post Office is run by the government, the Atlanta Hawks are a professional basketball team and cannabis companies were established to profit off of the booming legal cannabis industry.But unfortunately, these very different organizations do in fact have something in common. And it just so happens that it is a very important thing. They are all losing money! None of them have made a profit in years!Obviously, the Post Office can continue to lose money forever because it's run by the governmental and the government can just raise taxes. And a professional sports team can continue to lose money as long as the owners are willing to sustain the losses.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut let's talk about the cannabis companies In the stock market, the idea is to invest in companies that are, or will be, profitable. This profitability will, in turn, lead to the share price appreciating. Financial theory, history and common sense all tell us that if a company doesn't make money it will eventually go out of business. Investors will see declining share prices and losses.Looking at the Cannabis Companies: You are probably familiar with the following companies if you trade or invest in the cannabis markets. They may have cool products and be in a cool industry, but if you are considering investing in them, it is important to understand that they are losing money. You may ask yourself, "how have they been able to lose money for a sustained period of time?"The answer is that they borrow money or issue stock and use these proceeds to cover their expenses. But eventually, the ability to do so will stop if they are never able to turn a profit. * 7 Strong Buy Stocks That Tick All the Boxes I am not saying that these companies will never earn money and that you can't profit by investing in their stocks. Some of them may eventually become great investments. My intent here is to express my belief that before making an investment in a company, one should consider if it is actually making money and what the future prospects of profitability are. In the long run, these dynamics will ultimately have a significant effect on the share price. Axim Biotechnologies (AXIM) Click to Enlarge Axim Biotechnologies (OTCMKTS:AXIM) makes a really cool product. It is a biotechnology company based in New York City. The company makes chewing gum that is infused with medicinal cannabis. This is used to treat pain, anxiety and other conditions. It can even be used to treat opioid addiction, which we all know is a terrible epidemic. I am not really sure how they do it because I'm a stock market guy, not a scientist, but I think it sounds like an awesome idea.But let's take a look at some numbers. Last year AXIM lost 12 cents per share. That means that for the year the company lost about $6.7 million. Unfortunately, losing money is nothing new to this company. In 2017 they lost $4.2 million, in 2016 the loss was $7.3 million, and it 2015 it was just over $10 million.Not surprisingly, the stock has not acted well. It is currently trading around the $1.50 level. As you can see on the chart, over the past year it has lost about 70% of its value. Maybe someday one of the company's product will be a huge success and it will become profitable, but over the past few years, it has certainly been a disappointment to shareholders. Americann (ACAN) Click to Enlarge Americann, Inc. (OTCMKTS:ACAN) is next on the list. Like many other cannabis companies, they are based in Denver. This company develops medical cannabis cultivation and processing properties. In other words, they build greenhouses. The greenhouses they build aren't like the kind my grandfather had in his garden. These are big-time greenhouses that are used for largescale industrial growing. They have built and developed over one million square feet of growing area.Americann has been involved with some enormous projects. Some of the projects include the Denver Medical Cannabis Center, the Massachusetts Medical Cannabis Center and the Illinois Medical Cannabis Center. The company is also committed to sustainability and uses clean energy from solar and geothermal sources. * 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund Apparently, the Cannabis greenhouse business isn't very profitable -- at least in the way that Americann does it. Last year they lost $4.4 million which equates to a loss of 22 cents per share. This is more than they lost in the prior few years. In 2017 the loss was $2.7 million, in 2016 it was $2.2 million, and in 2015 the loss was $1.7 million. Maybe one day the company will be profitable but, as for now, they seem to be headed in the wrong direction. General Cannabis Corp. (CANN) Click to Enlarge General Cannabis Corp. (OTCMKTS:CANN) is a holding company that is based in Denver. They have four different segments -- security, operations, consumer goods and investments.The security segment provides different types of services to cannabis growers and retails stores. These services include video surveillance, transporting cash and providing security professionals. Consulting services to the cannabis industry that include obtaining licenses, compliance, logistics, retail operations and facility services are offered by the operations segment. The consumer goods segment includes developing relationships with apparel retailers and distributors. The investments segment provides loans and financing to companies within the cannabis industry.General cannabis is clearly an organization that is involved in many things. Maybe it is involved in too many things. Have you ever heard the expression "jack of all trades and master of none?" I think that could apply here. This company hasn't earned any money in years. Last year it lost almost $17 million, or 49 cents per share. The prior year's losses were less than half of that. In 2017, the loss was just over $8 million. In 2016, General cannabis lost just over $10 million and, in 2015, the loss was almost $9 million. If you're keeping track, this company has lost a total of $44 million in the past four years. Cannabis Sativa (CBDS) Click to Enlarge Cannabis Sativa, Inc. (OTCMKTS:CBDS) is next up on the list of losers. After looking at the company website for a while, I couldn't even figure out just what they actually do. I think it has something to do with providing services to cannabis dispensaries. Here is the description from MarketWatch:"Cannabis Sativa, Inc. engages in the research, development, acquisition and licensing of specialized natural cannabis related products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company was founded on November 5, 2005 and is headquartered in Mesquite, NV."This company seems very mysterious to me. According to MarketWatch, there is only one employee despite having revenues that were over $500 million. One of the things that I noticed when I was looking at the financials is that the Quick Ratio is only 0.25 while the average Quick Ratio for the industry is 2.67.The Quick Ratio is the company's cash and short-term securities divided by the current liabilities. Current typically means one year or less. In other words, Cannabis Sativa only has 25 cents for each dollar of debt that they have, while the industry average is to have $2.61 for each $1 of debt. With a ratio like that, it isn't surprising that they are losing money. * 7 Energy Stocks to Buy to Light Up Your Portfolio The losses were $4.1 million in 2018, $7.6 million in 2017, $3.1 million in 2016, and $9.4 million in 2015. Tilray (TLRY) Click to Enlarge Tilray Inc. (NASDAQ:TLRY) hasn't been a publicly traded company for that long. The initial public offering was last summer. This company has the distinction of being the first publicly traded cannabis company to list on the Nasdaq. Their business model is very understandable. They engage in research, cultivation, production, and distribution of cannabis and cannabinoids. Products include dried cannabis and cannabis extracts. In other words, they grow and sell weed.Like the others, this company is losing money as well. I have heard that the cannabis markets are glutted and that the price of cannabis has fallen dramatically since its legalization. Many cannabis farmers are losing a lot of money. Maybe that is why Tilray is losing money as well.Tilray went public last year, but they have disclosed financial information going back further. If you think about it, it is kind of amazing that a company that loses money could go public. This was a common occurrence back in the dot-com era. The company has a market capitalization of around $5 billion despite the fact that they lost $67 million last year. In 2017, they lost about $8 million and had a similar size loss in 2016. 22nd Century Group (XXII) Click to Enlarge 22nd Century Group, Inc. (OTCMKTS:XXII) is based in Clarence, New York. It is a biotech company. They research and develop technologies that will allow the increase or decrease of the levels of nicotine and nicotinic alkaloids in tobacco plants and the levels of cannabinoids in cannabis plants. My guess is that there will be greater demand for increasing than decreasing. This is done through genetic engineering and plant breeding. Sounds like pretty neat stuff.But don't let their cool name and cool stock symbol fool you. They are losing money. Last year the loss was $10.4 million. That is a loss of 8 cents per share. In 2017, the annual loss was close to $17 million. The loss in 2016 was just over $15 million and the loss in 2015 was just over $14 million. * 7 Stocks Worth Buying When They're Down Maybe this company will turn around one day and become successful, but the current shareholders must be disappointed. The valuation has fallen by about one-third since December as the price per share has fallen from $3 to $2 while the broader equity markets have been booming since then. The Supreme Cannabis Co (SPRWF) Click to Enlarge The Supreme Cannabis Co, Inc. (OTCMKTS:SPRWF) is last on the list. Obviously, there are many other cannabis companies that are losing money out there, but today I just wanted to focus on these seven because they seem to be popular recently. Supreme has a similar business model as Tilray. The company grows and sells cannabis, although the product may be a little different because they say it is '"sun-grown." I suppose this is in contrast to being grown with artificial light. Supreme does this through their wholly owned subsidiary 7ACRES.Perhaps The Supreme Cannabis Company should consider changing their name to "The Subprime Cannabis Company" because it is losing money. It has seen the price of its stock fall by about 20% since September. Last year the company lost around $7.3 million. Losses in 2017 were more than twice that at $15.3 million. The loss in 2016 was $4.4 million and the loss in 2015 was about $5.7 million. Maybe the future will be better, but my guess is that The Supreme Cannabis Company's shareholders are supremely disappointed.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks to Buy to Light Up Your Portfolio * 10 Vice Stocks to Spice Up Your Portfolio * 7 of the Best ETFs to Buy for a Slowing Economy Compare Brokers The post 7 Marijuana Stocks That Are Bleeding Cash appeared first on InvestorPlace.
Musical rapper Drake is said to partner with Canopy Growth to sell recreational weed and accessories. Marijuana Business Daily Founding Editor, Chris Walsh, joins Yahoo Finance’s Adam Shapiro, Andy Serwer and BNY Mellon Chief Strategist Alicia Levine to shed light on the cannabis partnership.